If All You See…

…are horrible fossil fueled vehicles, you might just be a Warmist

The blog of the day is The First Street Journal, with a post on due process of law gone missing.

It’s country women week!

Save $10 on purchases of $49.99 & up on our Fruit Bouquets at 1800flowers.com. Promo Code: FRUIT49
If you liked my post, feel free to subscribe to my rss feeds.

Both comments and trackbacks are currently closed

4 Responses to “If All You See…”

  1. HMCS(FMF) ret says:

    She looks friendly… in a country way!

  2. Elwood P. Dowd says:

    Potentially good news on the vaccine front.

    https://marlin-prod.literatumonline.com/pb-assets/Lancet/pdfs/S0140673620316044.pdf

    Oxford/AstraZeneca announced Phase I/II results showing their adenovirus-based SARS-CoV-2 spike protein vaccine stimulated both an antibody (humoral) response and a T-lymphocyte-mediated (cellular) response to the spike protein. They have a large Phase III trial ongoing. It’s possible to have a vaccine early in 2021!

    In conclusion, ChAdOx1 nCoV-19 was safe, tolerated, and immunogenic, while reactogenicity was reduced with paracetamol (Tylenol). A single dose elicited both humoral
    and cellular responses against SARS-CoV-2, with a booster immunisation augmenting neutralising antibody titres. The preliminary results of this first-in-human
    clinical trial supported clinical development progression into ongoing phase 2 and 3 trials. Older age groups with comorbidities, health-care workers, and those with
    higher risk for SARS-CoV-2 exposure are being recruited and assessed for efficacy, safety, and immunogenicity of ChAdOx1 nCoV-19 given as a single-dose or two-dose
    administration regimen in further trials conducted in the UK and overseas. We will also evaluate the vaccine in children, once sufficient safety data have been accumulated in adult studies. Phase 3 trials are now underway in Brazil, South Africa, and the UK and will evaluate vaccine efficacy in diverse populations.

Pirate's Cove